ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record7 judgments2 judges (the rules as one: Rule based)18 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06203600Adding Nivolumab to UsualTreatment for People WithAdvanced Stomach orEsophageal Cancer, PARAMUNETrialNational Cancer Institute (NCIPhase 2/Phase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 25 · ClinicalTrials.gov record · Version of 2026-09-25Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Oct 29 · ClinicalTrials.gov record · Version of 2026-10-29Oct 30 · ClinicalTrials.gov record · Version of 2026-10-30Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSAdenocarcinoma Of EsophagusThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundRamucirumabIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Nivolumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Nivolumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 25The record itselfClinicalTrials.gov recordVersion of 2026-09-25Record change
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Oct 23The record itselfClinicalTrials.gov recordVersion of 2026-10-23Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 28The record itselfClinicalTrials.gov recordVersion of 2026-10-28Record change
Oct 29The record itselfClinicalTrials.gov recordVersion of 2026-10-29Record change
Oct 30The record itselfClinicalTrials.gov recordVersion of 2026-10-30Record change
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 2RamucirumabClaude Opus 5.5BackgroundCurrent
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18RamucirumabRule based · role ruleBackgroundAgrees
As of nowAdenocarcinoma Of EsophagusRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.